Given Zydus Lifesciences and Dr Reddy’s Laboratories have high US sales exposure with ~45% and 43% sales contribution, ...

Trump had earlier said on March 24 that he will announce tariffs on automobiles, pharmaceuticals and aluminum in the near ...

NPPA asks Bayer Zydus Pharma to continue selling Urografin for one more year: Gireesh Babu, New Delhi Saturday, March 29, 2025, 08:00 Hrs [IST] The National Pharmaceutical Pricing ...

Jefferies pointed out that India currently imposes up to 10% import duties on US drugs, with some having lower duties or ...

Pharmaceutical company shares faced significant selling pressure, causing the Nifty Pharma index to decline by more than 2 ...

Citi's analysis indicates that companies with lower exposure to US generics, including Torrent Pharma, Sun Pharma, and Divi's ...

What sectors will be most impacted by Trump reciprocal tariffs that will go into effect on April 2: Donald Trump's Reciprocal ...

Sun Pharma and Zydus Pharmaceuticals recall products in the US due to manufacturing issues, according to the US FDA. The recalls affect Morphine Sulfate and Nelarabine Injection.

Sun Pharma and Zydus Pharmaceuticals are recalling products in the US market due to manufacturing issues, according to the US Food and Drug Administration (USFDA). The New Jersey-based Sun ...

Zydus Lifesciences Ltd has received final approval from the USFDA to manufacture 60 mg Apalutamide tablets for prostate ...

The rise in the Zydus Lifesciences shares came after the company received final approval from the United States Food and Drug ...